Table 2 Orphan medicinal product expenditure within and outside marketing exclusivity period
From: Costs of orphan medicinal products: longitudinal analysis of expenditure in Wales
Total spend, £, million (number of unique OMPs) | ||||||||
|---|---|---|---|---|---|---|---|---|
Secondary Care | Primary Care | Specialist Commissioned | Total spend | |||||
Financial period | Within MEP | Outside MEP | Within MEP | Outside MEP | Within MEP | Outside MEP | Within MEP | Outside MEP |
2009/10 | 6.76 (41) | 1.98 (1) | 6.76 (41) | 1.98 (1) | ||||
2010/11 | 7.05 (43) | 2.47 (1) | 7.05 (43) | 2.47 (1) | ||||
2011/12 | 8.47 (45) | 2.50 (2) | 8.47 (45) | 2.50 (2) | ||||
2012/13 | 10.16 (46) | 2.03 (4) | 10.16 (46) | 2.03 (4) | ||||
2013/14 | 11.21 (44) | 3.36 (8) | 11.21 (44) | 3.36 (8) | ||||
2014/15 | 14.92 (47) | 3.42 (9) | 1.80 (21) | 3.23 (3) | 7.74 (26) | 1.26 (6) | 24.46 (57) | 7.91 (11) |
2015/16 | 17.27 (47) | 3.78 (13) | 1.89 (21) | 3.35 (6) | 9.39 (31) | 1.74 (7) | 28.55 (60) | 8.87 (16) |
2016/17 | 23.20 (55) | 5.37 (17) | 2.08 (23) | 3.32 (9) | 11.29 (32) | 2.08 (11) | 36.57 (67) | 10.77 (21) |
2017/18 | 27.07 (57) | 6.24 (23) | 1.47 (19) | 1.99 (11) | 13.26 (36) | 2.30 (14) | 41.80 (69) | 10.53 (27) |
2018/19 | 33.86 (61) | 12.01 (30) | 1.34 (15) | 1.66 (14) | 9.85 (33) | 9.63 (13) | 45.05 (70) | 23.30 (35) |
2019/20 | 37.48 (64) | 18.45 (39) | 1.22 (15) | 1.47 (15) | 13.18 (38) | 10.53 (16) | 51.88 (72) | 30.45 (44) |